Where Will Hershey Stock Be In 1 Year?
Chocolate stocks used to be the epitome of sleepy stability,…
Sell
33
XHS Quote, Financials, Valuation and Earnings
Last price:
$96.74
Seasonality move
:
0.7%
Day range:
$96.39 - $98.79
52-week range:
$88.10 - $103.50
Dividend yield:
0.29%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
22.4K
Avg. volume:
10.9K
1-year change:
7.83%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
XHS
SPDR S&P Health Care Services ETF
|
-- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
XHS
SPDR S&P Health Care Services ETF
|
$96.45 | -- | -- | -- | $0.06 | 0.29% | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
$163.76 | -- | -- | -- | $1.17 | 0.72% | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
$65.43 | -- | -- | -- | $0.13 | 0.25% | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
$81.29 | -- | -- | -- | $0.27 | 1.19% | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
$29.18 | -- | -- | -- | $0.06 | 0.76% | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
$41.23 | -- | -- | -- | $0.10 | 1.45% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
XHS
SPDR S&P Health Care Services ETF
|
-- | 1.060 | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | 0.653 | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | 0.915 | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | 0.248 | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | 0.851 | -- | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
-- | 0.358 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
XHS
SPDR S&P Health Care Services ETF
|
-- | -- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
SPDR S&P Health Care Services ETF vs. Competitors
-
Which has Higher Returns XHS or FBT?
First Trust NYSE Arca Biotechnology Index Fund has a net margin of -- compared to SPDR S&P Health Care Services ETF's net margin of --. SPDR S&P Health Care Services ETF's return on equity of -- beat First Trust NYSE Arca Biotechnology Index Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHSSPDR S&P Health Care Services ETF-- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -
What do Analysts Say About XHS or FBT?
SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust NYSE Arca Biotechnology Index Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Services ETF has higher upside potential than First Trust NYSE Arca Biotechnology Index Fund, analysts believe SPDR S&P Health Care Services ETF is more attractive than First Trust NYSE Arca Biotechnology Index Fund.
Company Buy Ratings Hold Ratings Sell Ratings XHSSPDR S&P Health Care Services ETF0 0 0 FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 -
Is XHS or FBT More Risky?
SPDR S&P Health Care Services ETF has a beta of 1.018, which suggesting that the stock is 1.773% more volatile than S&P 500. In comparison First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.641, suggesting its less volatile than the S&P 500 by 35.874%.
-
Which is a Better Dividend Stock XHS or FBT?
SPDR S&P Health Care Services ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.29%. First Trust NYSE Arca Biotechnology Index Fund offers a yield of 0.72% to investors and pays a quarterly dividend of $1.17 per share. SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. First Trust NYSE Arca Biotechnology Index Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHS or FBT?
SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than First Trust NYSE Arca Biotechnology Index Fund quarterly revenues of --. SPDR S&P Health Care Services ETF's net income of -- is lower than First Trust NYSE Arca Biotechnology Index Fund's net income of --. Notably, SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while First Trust NYSE Arca Biotechnology Index Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Services ETF is -- versus -- for First Trust NYSE Arca Biotechnology Index Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHSSPDR S&P Health Care Services ETF-- -- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- --
-
Which has Higher Returns XHS or PBE?
Invesco Biotechnology & Genome ETF has a net margin of -- compared to SPDR S&P Health Care Services ETF's net margin of --. SPDR S&P Health Care Services ETF's return on equity of -- beat Invesco Biotechnology & Genome ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHSSPDR S&P Health Care Services ETF-- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- -
What do Analysts Say About XHS or PBE?
SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Biotechnology & Genome ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Services ETF has higher upside potential than Invesco Biotechnology & Genome ETF, analysts believe SPDR S&P Health Care Services ETF is more attractive than Invesco Biotechnology & Genome ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHSSPDR S&P Health Care Services ETF0 0 0 PBEInvesco Biotechnology & Genome ETF0 0 0 -
Is XHS or PBE More Risky?
SPDR S&P Health Care Services ETF has a beta of 1.018, which suggesting that the stock is 1.773% more volatile than S&P 500. In comparison Invesco Biotechnology & Genome ETF has a beta of 0.810, suggesting its less volatile than the S&P 500 by 19.007%.
-
Which is a Better Dividend Stock XHS or PBE?
SPDR S&P Health Care Services ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.29%. Invesco Biotechnology & Genome ETF offers a yield of 0.25% to investors and pays a quarterly dividend of $0.13 per share. SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. Invesco Biotechnology & Genome ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHS or PBE?
SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than Invesco Biotechnology & Genome ETF quarterly revenues of --. SPDR S&P Health Care Services ETF's net income of -- is lower than Invesco Biotechnology & Genome ETF's net income of --. Notably, SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while Invesco Biotechnology & Genome ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Services ETF is -- versus -- for Invesco Biotechnology & Genome ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHSSPDR S&P Health Care Services ETF-- -- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- --
-
Which has Higher Returns XHS or PJP?
Invesco Pharmaceuticals ETF has a net margin of -- compared to SPDR S&P Health Care Services ETF's net margin of --. SPDR S&P Health Care Services ETF's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHSSPDR S&P Health Care Services ETF-- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- -
What do Analysts Say About XHS or PJP?
SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Services ETF has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe SPDR S&P Health Care Services ETF is more attractive than Invesco Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHSSPDR S&P Health Care Services ETF0 0 0 PJPInvesco Pharmaceuticals ETF0 0 0 -
Is XHS or PJP More Risky?
SPDR S&P Health Care Services ETF has a beta of 1.018, which suggesting that the stock is 1.773% more volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.502, suggesting its less volatile than the S&P 500 by 49.771%.
-
Which is a Better Dividend Stock XHS or PJP?
SPDR S&P Health Care Services ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.29%. Invesco Pharmaceuticals ETF offers a yield of 1.19% to investors and pays a quarterly dividend of $0.27 per share. SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHS or PJP?
SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. SPDR S&P Health Care Services ETF's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Services ETF is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHSSPDR S&P Health Care Services ETF-- -- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns XHS or RSPH?
Invesco S&P 500 Eql Wght Health Care ETF has a net margin of -- compared to SPDR S&P Health Care Services ETF's net margin of --. SPDR S&P Health Care Services ETF's return on equity of -- beat Invesco S&P 500 Eql Wght Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHSSPDR S&P Health Care Services ETF-- -- -- RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -
What do Analysts Say About XHS or RSPH?
SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P 500 Eql Wght Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Services ETF has higher upside potential than Invesco S&P 500 Eql Wght Health Care ETF, analysts believe SPDR S&P Health Care Services ETF is more attractive than Invesco S&P 500 Eql Wght Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHSSPDR S&P Health Care Services ETF0 0 0 RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 -
Is XHS or RSPH More Risky?
SPDR S&P Health Care Services ETF has a beta of 1.018, which suggesting that the stock is 1.773% more volatile than S&P 500. In comparison Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.880, suggesting its less volatile than the S&P 500 by 11.971%.
-
Which is a Better Dividend Stock XHS or RSPH?
SPDR S&P Health Care Services ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.29%. Invesco S&P 500 Eql Wght Health Care ETF offers a yield of 0.76% to investors and pays a quarterly dividend of $0.06 per share. SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. Invesco S&P 500 Eql Wght Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHS or RSPH?
SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues of --. SPDR S&P Health Care Services ETF's net income of -- is lower than Invesco S&P 500 Eql Wght Health Care ETF's net income of --. Notably, SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while Invesco S&P 500 Eql Wght Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Services ETF is -- versus -- for Invesco S&P 500 Eql Wght Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHSSPDR S&P Health Care Services ETF-- -- -- -- RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- --
-
Which has Higher Returns XHS or XPH?
SPDR S&P Pharmaceuticals ETF has a net margin of -- compared to SPDR S&P Health Care Services ETF's net margin of --. SPDR S&P Health Care Services ETF's return on equity of -- beat SPDR S&P Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XHSSPDR S&P Health Care Services ETF-- -- -- XPHSPDR S&P Pharmaceuticals ETF-- -- -- -
What do Analysts Say About XHS or XPH?
SPDR S&P Health Care Services ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that SPDR S&P Health Care Services ETF has higher upside potential than SPDR S&P Pharmaceuticals ETF, analysts believe SPDR S&P Health Care Services ETF is more attractive than SPDR S&P Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings XHSSPDR S&P Health Care Services ETF0 0 0 XPHSPDR S&P Pharmaceuticals ETF0 0 0 -
Is XHS or XPH More Risky?
SPDR S&P Health Care Services ETF has a beta of 1.018, which suggesting that the stock is 1.773% more volatile than S&P 500. In comparison SPDR S&P Pharmaceuticals ETF has a beta of 0.623, suggesting its less volatile than the S&P 500 by 37.686%.
-
Which is a Better Dividend Stock XHS or XPH?
SPDR S&P Health Care Services ETF has a quarterly dividend of $0.06 per share corresponding to a yield of 0.29%. SPDR S&P Pharmaceuticals ETF offers a yield of 1.45% to investors and pays a quarterly dividend of $0.10 per share. SPDR S&P Health Care Services ETF pays -- of its earnings as a dividend. SPDR S&P Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XHS or XPH?
SPDR S&P Health Care Services ETF quarterly revenues are --, which are smaller than SPDR S&P Pharmaceuticals ETF quarterly revenues of --. SPDR S&P Health Care Services ETF's net income of -- is lower than SPDR S&P Pharmaceuticals ETF's net income of --. Notably, SPDR S&P Health Care Services ETF's price-to-earnings ratio is -- while SPDR S&P Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SPDR S&P Health Care Services ETF is -- versus -- for SPDR S&P Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XHSSPDR S&P Health Care Services ETF-- -- -- -- XPHSPDR S&P Pharmaceuticals ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will KNOT Stock Be In 1 Year?
In the case of KNOT Offshore Partners (KNOP), most headlines…
Why Is Goldman Sachs Stock Up So Much?
Investment banking giant Goldman Sachs (NYSE:GS) has sharply outperformed the…
Stock Ideas
Buy
63
Is NVDA Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 53x
Buy
60
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 42x
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
92
BGL alert for Jul 3
Blue Gold [BGL] is down 20.3% over the past day.
Sell
18
CNC alert for Jul 3
Centene [CNC] is down 1.3% over the past day.
Sell
12
MOH alert for Jul 3
Molina Healthcare [MOH] is up 0.3% over the past day.
